One synthetic peptide reaches three receptor systems that each shape appetite, blood glucose and fat metabolism, which is why retatrutide has become one of the most closely watched research compounds in metabolic science
Tirzepatide is the agonist of GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor, which can reduce body weight and improve cardiac metabolism by subcutaneous injection once a week (Jastreboff et al 2022)
Ferran, M., Calvet, J., Almirall, M., Pujol, R
Long-term success depends on nutrition, exercise, sleep, and regular medical follow-up. Dr
In research, this double action distinguishes it from uni-action medications, enabling it to be more adaptable for individuals with both diabetes and obesity